Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06438445
NA

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

Sponsor: Universidade Federal Fluminense

View on ClinicalTrials.gov

Summary

The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).

Official title: Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-07-30

Completion Date

2026-04-05

Last Updated

2025-04-04

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Real Jelly

Participants will receive 500mg of royal jelly capsules per day for two months.

DIETARY_SUPPLEMENT

Placebo

Participants will receive 500mg of placebo capsules per day for two months.

Locations (1)

Denise Mafra

Rio de Janeiro, Rio de Janeiro, Brazil